Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Asset Utilization Ratio: 2011-2025

Historic Asset Utilization Ratio for Ironwood Pharmaceuticals (IRWD) over the last 14 years, with Sep 2025 value amounting to 0.92.

  • Ironwood Pharmaceuticals' Asset Utilization Ratio fell 4.83% to 0.92 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.92, marking a year-over-year decrease of 4.83%. This contributed to the annual value of 0.86 for FY2024, which is 51.76% up from last year.
  • As of Q3 2025, Ironwood Pharmaceuticals' Asset Utilization Ratio stood at 0.92, which was down 0.36% from 0.92 recorded in Q2 2025.
  • Ironwood Pharmaceuticals' Asset Utilization Ratio's 5-year high stood at 0.96 during Q3 2024, with a 5-year trough of 0.37 in Q1 2023.
  • In the last 3 years, Ironwood Pharmaceuticals' Asset Utilization Ratio had a median value of 0.92 in 2025 and averaged 0.82.
  • Per our database at Business Quant, Ironwood Pharmaceuticals' Asset Utilization Ratio crashed by 53.56% in 2021 and then surged by 145.79% in 2024.
  • Over the past 5 years, Ironwood Pharmaceuticals' Asset Utilization Ratio (Quarterly) stood at 0.38 in 2021, then climbed by 2.27% to 0.38 in 2022, then surged by 131.97% to 0.89 in 2023, then grew by 6.68% to 0.95 in 2024, then dropped by 4.83% to 0.92 in 2025.
  • Its last three reported values are 0.92 in Q3 2025, 0.92 for Q2 2025, and 0.94 during Q1 2025.